Inventor · disambiguated record
Shenghua Shi
Also filed as: SHI SHENGHUA
10 granted patents·14 pending applications·860 citations·filing 1998–2017
94Inventor score
Top patents by PatentIndex Score
24 records- 0198US8470818B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 25, 2013·94 cites·56 claims
- 0298US8415469B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 9, 2013·84 cites·18 claims
- 0398US7863288B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2006·Granted Jan 4, 2011·187 cites·54 claims
- 0497US7863289B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2007·Granted Jan 4, 2011·131 cites·24 claims
- 0595US8053463B2PPAR active compoundsPLEXXIKON INC·Filed 2008·Granted Nov 8, 2011·45 cites·8 claims
- 0695US7531568B2PPAR active compoundsPLEXXIKON INC·Filed 2005·Granted May 12, 2009·51 cites·12 claims
- 0795US6875760B2Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 2002·Granted Apr 5, 2005·56 cites·80 claims
- 0895US6503949B1Glucagon antagonists/inverse agonistsNORO NORDISK AS·Filed 2000·Granted Jan 7, 2003·67 cites·56 claims
- 0993US8268858B2Compounds and methods for kinase modulation, and indications thereforWU GUOXIAN·Filed 2007·Granted Sep 18, 2012·49 cites·11 claims
- 1087US6613942B1Glucagon antagonists/inverse agonistsNOVO NORDISK AS·Filed 1998·Granted Sep 2, 2003·96 cites·50 claims
- 1165US2018111929A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Application pending·0 cites
- 1263US2013303534A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Application pending·0 cites
- 1360US2009143592A1Glucagon Antagonists/Inverse AgonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1460US2016176865A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 1560US2012053177A1Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2011·Application pending·0 cites
- 1658US2015290205A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Application pending·0 cites
- 1754US2005203108A1Glucagon antagonists/inverse agonistsFiled 2004·Application pending·0 cites
- 1849US2008221127A1Ppar active compoundsPLEXXIKON INC·Filed 2008·Application pending·0 cites
- 1947US2012015966A1Ppar active compoundsLIN JACK·Filed 2011·Application pending·0 cites
- 2045US2008234349A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 2145US2008249137A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 2245US2011092538A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2010·Application pending·0 cites
- 2345US2007072904A1PPAR active compoundsLIN JACK·Filed 2006·Application pending·0 cites
- 2443US2006135540A1PPAR active compoundsLIN JACK·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shenghua Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →